Clinical Trial Update: Testing the Addition of Ipatasertib to the Usual Chemotherapy Treatment (Paclitaxel and Carboplatin) for Stage III or IV Epithelial Ovarian Cancer [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating adding ipatasertib to paclitaxel and carboplatin for Stage III/IV ovarian, fallopian tube, and primary peritoneal cancers; results have…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fallopian Tube Cancer
• Ovarian Cancer
• Peritoneal Cancer

Drugs mentioned

• Paraplatin (carboplatin) (carboplatin)
• Taxol (paclitaxel) (paclitaxel)
• ipatasertib (ipatasertib)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Fallopian Tube Endometrioid Adenocarcinoma, Fallopian Tube High Grade Serous Adenocarcinoma | Phase 1 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2025-12-19